(Q41327576)

29 September 2017

Proton pump inhibitors: balancing the benefits and potential fracture risks (English)

1 reference

29 September 2017

J Brent Richards

1

1 reference

29 September 2017

David Goltzman

series ordinal

2

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

Canadian Medical Association Journal

29 September 2017

2

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 September 2017

179

1 reference

29 September 2017

4

1 reference

29 September 2017

306-307

1 reference

Use of proton pump inhibitors and risk of osteoporosis-related fractures

29 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492957

Proton pump-inhibiting drugs, calcium homeostasis, and bone health

1 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492957

Long-term proton pump inhibitor therapy and risk of hip fracture

1 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2492957

Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture

1 October 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18695170

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1503/CMAJ.080873

1 reference

29 September 2017

1 reference

29 September 2017

PubMed publication ID

18695170

1 reference